National real estate development and construction services provider The McShane Companies announced that its Board of Directors has appointed Molly McShane as Chief Executive Officer effective October 1, 2020. Ms. McShane previously held the position of Chief Operating Officer.
“During this time of transformation, there is no better person to lead The McShane Companies than Molly,” said Jim McShane, company Founder and Chairman of the Board. “Molly is a proven leader with a clear business vision and the ability to bring people together. Her vision for growth and diversification is exactly what The McShane Companies needs as we enter our next chapter.”
Since joining the company in 2002, McShane has spearheaded strategic initiatives across its portfolio of services, notably its expansion into new geographic markets and a conscious effort to create a diverse workplace. During her tenure as Chief Operating Officer, the organization posted record growth. (The McShane Companies posted $1.3 billion in construction revenues in 2019 and ranked #41 among Contractors in Building Design+Construction's 2020 Giants 400 rankings.) Before serving as COO, Molly was Chief Investment Officer – and the first woman to rise to the C-suite leadership level in the firm’s history.
“It is a privilege to be part of an organization that delivers high-quality services and innovative solutions to the best clients. We are committed to developing the most talented professionals into leaders, and we will do our part to improve and give back to the communities in which we operate,” said McShane. “I am committed to upholding the principles of ethics and service that have gotten us to where we are today.”
McShane was named NAIOP Chicago’s first female President in 2018. She was also a founding co-chair of WLI Chicago’s executive board. Crain’s Chicago Business has included her on its lists of Notable Women in Construction and Notable Women in Commercial Real Estate. She was also named to GlobeSt.’s Women of Influence Hall of Fame and received Connect Media’s Women in Real Estate Award.
McShane received an undergraduate degree in marketing from Boston College and an MBA from Northwestern University’s Kellogg School of Management.
Related Stories
| Mar 16, 2012
Temporary fix to CityCenter's Harmon would cost $2 million, contractor says
By contrast, CityCenter half-owner and developer MGM Resorts International determined last year that the Harmon would collapse in a strong quake and can't be fixed in an economical way. It favors implosion at a cost of $30 million.
| Mar 16, 2012
Work on Oxnard, Calif. shopping center resumes after a three-year hiatus
Stalled since 2009, developers of the Collection at RiverPark decided to restart construction on the outdoor mall.
| Mar 16, 2012
Stego embarks on HPD Pilot Program
Vapor barrier manufacturer strives to provide better green choices to designers and builders.
| Mar 16, 2012
Marvin Windows and Doors accepting entries for fourth-annual myMarvin Architect’s Challenge
Architects in U.S. and abroad offered the chance to showcase their very best work.
| Mar 14, 2012
Hearing to decide fate of unfinished Harmon in Las Vegas under way
The testimony began with CityCenter consulting engineer Chukwuma Ekwueme methodically showing photo after photo of parts of the Harmon, where he and his team had chipped away the concrete pillars and beams to examine the steel reinforcing bars inside.
| Mar 14, 2012
Firestone names 2012 Master Contractor Award Winners
Annual award acknowledges industry’s top roofing professionals.
| Mar 14, 2012
Plans for San Francisco's tallest building revamped
The glassy white high-rise would be 60 stories and 1,070 feet tall with an entrance at First and Mission streets.
| Mar 14, 2012
Hyatt joins Thornton Tomasetti as VP in Chicago
A forensic specialist, Hyatt has more than 10 years of experience performing investigations of structural failures throughout the U.S.
| Mar 14, 2012
Tsoi/Kobus and Centerbrook to design Jackson Laboratory facility in Farmington, Conn.
Building will house research into personalized, gene-based cancer screening and treatment.
